nimodipine has been researched along with Hemiplegia, Crossed in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dannenberg, F | 1 |
| Prager, C | 1 |
| Schmidt, F | 1 |
| Tietze, A | 1 |
| Bittigau, P | 1 |
| Kaindl, AM | 1 |
| Camaioni, D | 1 |
| Mignani, V | 1 |
| Mascaro, A | 1 |
| Barbi, S | 1 |
| Evangelista, M | 1 |
2 other studies available for nimodipine and Hemiplegia, Crossed
| Article | Year |
|---|---|
Intravenous Nimodipine Treatment for Severe Episode of ATP1A2 Hemiplegic Migraine.
Topics: Administration, Intravenous; Adolescent; Calcium Channel Blockers; Female; Hemiplegia; Humans; Migra | 2020 |
[Nimodipine for the treatment of hemiplegic migraine. Description of a clinical case].
Topics: Female; Hemiplegia; Humans; Migraine Disorders; Nimodipine | 1990 |